Sigachi Industries Ltd
Sigachi Industries Q2 FY26: Capex ₹60 Cr
Q2 FY26 earnings call: what management said on revenue, margins and capex.
Guidance rank: #10 of 83 in Pharmaceuticals & Biotechnology
See the sector's top 10 — free with your mobile number.
Sigachi Industries Ltd Q2 FY26 key numbers
- Revenue
- An additional 12,000 metric tons capacity expansion planned, expected to generate around Rs.250 crore in revenue moving forward.
As stated in Sigachi Industries Ltd's Q2 FY26 earnings call transcript · published 5 Aug 2026. Reported figures, not investment advice.
The short version
Sigachi aims for consistent and sustainable growth over the next 2-3 years driven by excipients, APIs, and O&M services. The company aims for consistent and sustainable growth over the next 2-3 years driven by excipients, APIs, and O&M services. - Expansion of capacity, strengthening product mix, and enhancing profitability through operational excellence and disciplined execution are key focus areas. - The additional 12,000 metric tons MCC capacity is expected to generate peak revenue of around Rs.
From Sigachi Industries Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Sigachi aims for consistent and sustainable growth over the next 2-3 years driven by excipients, APIs, and O&M services. (Page 5)
- The company expects to achieve not less than Rs.575 crore revenue by FY26 with potential for further increase by March-end. (Page 18)
- An additional 12,000 metric tons capacity expansion planned, expected to generate around Rs.250 crore in revenue moving forward. (Page 18)
- FY27 will see partial revenue contributions from the new capacity along with regular growth from existing operations. (Page 18)
- Despite disruptions, the company expects Q3 and Q4 to stabilize and improve growth momentum. (Page 15, 18)
2 more points from Sigachi Industries Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Sigachi Industries Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- MCC 12,000 metric tons facility expansion planned with a CAPEX of around Rs.100 crores, expected to generate Rs.250 crores revenue at full capacity. (Page 20)
- CCS facility requires approximately Rs.60 crores additional CAPEX; Rs.33 crores already available; implementation ongoing. (Page 20)
- Orvakal facility plans are under consideration (API/MCC), with environmental clearance expected within 30 days; final decisions pending board approval. (Page 19)
- Minor capital spends planned on safety improvements and process upgrades across existing plants; no significant CAPEX expected for this. (Page 17)
2 more points from Sigachi Industries Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Pharmaceuticals & Biotechnology
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Sigachi Industries Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from Sigachi Industries Ltd's call on order book
Create a free account to keep reading this call
Sigachi Industries Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q3 FY26): revenue ₹117 Cr, net loss ₹0 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Sigachi Industries Ltd's management said in earlier quarters
- Q1 FY27 earnings call analysis →
- Q1 FY26 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q4 FY26 earnings call analysis →
- Q4 FY25 earnings call →
- Q3 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q3 FY23 earnings call →
Potential multibaggers · Q2 FY27
Potential multibaggers in Pharmaceuticals & Biotechnology
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Sigachi Industries Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Sigachi Industries Ltd Q2 FY26 results?
Sigachi aims for consistent and sustainable growth over the next 2-3 years driven by excipients, APIs, and O&M services. The company aims for consistent and sustainable growth over the next 2-3 years driven by excipients, APIs, and O&M services. - Expansion of capacity, strengthening product mix, and enhancing profitability through operational excellence and disciplined execution are key focus areas. - The additional 12,000 metric tons MCC capacity is expected to generate peak revenue of around Rs.
What is Sigachi Industries Ltd share price analysis?
Sigachi Industries Ltd currently shows a neutral. The stock trades at a P/E of 30.6 with a market cap of ₹995 Cr. Investors should review the full earnings analysis for detailed insights.
Is Sigachi Industries Ltd planning capital expenditure?
MCC 12,000 metric tons facility expansion planned with a CAPEX of around Rs.100 crores, expected to generate Rs.250 crores revenue at full capacity.
Keep Sigachi Industries Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.